AIRLINK 90.15 Increased By ▲ 1.42 (1.6%)
BOP 5.41 Increased By ▲ 0.34 (6.71%)
CNERGY 3.96 Increased By ▲ 0.09 (2.33%)
DFML 42.07 Decreased By ▼ -1.08 (-2.5%)
DGKC 90.20 Decreased By ▼ -0.28 (-0.31%)
FCCL 23.00 Increased By ▲ 0.32 (1.41%)
FFBL 38.00 Decreased By ▼ -0.15 (-0.39%)
FFL 9.30 Increased By ▲ 0.10 (1.09%)
GGL 9.70 Increased By ▲ 0.12 (1.25%)
HASCOL 6.10 Increased By ▲ 0.07 (1.16%)
HBL 132.50 Increased By ▲ 6.50 (5.16%)
HUBC 167.30 Increased By ▲ 3.30 (2.01%)
HUMNL 10.78 Increased By ▲ 0.16 (1.51%)
KEL 4.72 Increased By ▲ 0.01 (0.21%)
KOSM 4.18 Decreased By ▼ -0.07 (-1.65%)
MLCF 38.25 Increased By ▲ 0.45 (1.19%)
OGDC 136.79 Increased By ▲ 0.79 (0.58%)
PAEL 26.75 Increased By ▲ 1.75 (7%)
PIBTL 6.20 No Change ▼ 0.00 (0%)
PPL 124.68 Increased By ▲ 0.91 (0.74%)
PRL 23.85 Increased By ▲ 0.64 (2.76%)
PTC 12.30 Decreased By ▼ -0.33 (-2.61%)
SEARL 59.05 Increased By ▲ 0.37 (0.63%)
SNGP 68.11 Increased By ▲ 2.01 (3.04%)
SSGC 9.98 Increased By ▲ 0.16 (1.63%)
TELE 8.09 Increased By ▲ 0.49 (6.45%)
TPLP 8.90 Increased By ▲ 0.05 (0.56%)
TRG 62.00 Decreased By ▼ -0.30 (-0.48%)
UNITY 31.95 Increased By ▲ 0.66 (2.11%)
WTL 1.28 No Change ▼ 0.00 (0%)
BR100 8,508 Increased By 79.7 (0.95%)
BR30 27,459 Increased By 495.3 (1.84%)
KSE100 80,234 Increased By 680.8 (0.86%)
KSE30 25,799 Increased By 215.8 (0.84%)

The new chief executive of Merck & Co Inc on Friday gave Wall Street its first taste of his plan to revive the company, including exploring expansion into medical devices and diagnostics, according to an analyst.
Merck CEO Richard Clark laid out his vision for the company in a meeting with sell-side analysts, according to a note from J.P. Morgan analyst Chris Shibutani.
"Longer-term, we heard for the first time of the potential for how Merck could even envision itself as a company with businesses beyond pure pharma (pharmaceuticals), to include devices (implantable) and diagnostics as well," Shibutani said.

Copyright Reuters, 2005

Comments

Comments are closed.